Please select the option that best describes you:

Do you give neoadjuvant intralesional 5FU/MTX prior to Mohs for CSCC purely to reduce scar size and improve cosmetic outcome?  

I worry about introducing skip lesions and there is fairly limited data. 



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Community Practice
Sign in or Register to read more